Literature DB >> 30419314

Unraveling the journey of cancer stem cells from origin to metastasis.

Rama Krishna Nimmakayala1, Surinder K Batra2, Moorthy P Ponnusamy3.   

Abstract

Cancer biology research over recent decades has given ample evidence for the existence of self-renewing and drug-resistant populations within heterogeneous tumors, widely recognized as cancer stem cells (CSCs). However, a lack of clear understanding about the origin, existence, maintenance, and metastatic roles of CSCs limit efforts towards the development of CSC-targeted therapy. In this review, we describe novel avenues of current CSC biology. In addition to cell fusion and horizontal gene transfer, CSCs are originated by mutations in somatic or differentiated cancer cells, resulting in de-differentiation and reprogramming. Recent studies also provided evidence for the existence of distinct or heterogeneous CSC populations within a single heterogeneous tumor. Our analysis of the literature also opens the doors for a novel hypothesis that CSC populations with specific phenotypes, metabolic profiles, and clonogenic potential metastasize to specific organs.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer stem cells; de-differentiation; metabolic reprogramming

Mesh:

Year:  2018        PMID: 30419314      PMCID: PMC6347501          DOI: 10.1016/j.bbcan.2018.10.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  172 in total

Review 1.  Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation.

Authors:  L A Milner; A Bigas
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

Review 2.  ABC efflux pump-based resistance to chemotherapy drugs.

Authors:  Paul D W Eckford; Frances J Sharom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

3.  Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.

Authors:  Irene Miranda-Lorenzo; Jorge Dorado; Enza Lonardo; Sonia Alcala; Alicia G Serrano; Jenifer Clausell-Tormos; Michele Cioffi; Diego Megias; Sladjana Zagorac; Anamaria Balic; Manuel Hidalgo; Mert Erkan; Joerg Kleeff; Aldo Scarpa; Bruno Sainz; Christopher Heeschen
Journal:  Nat Methods       Date:  2014-09-28       Impact factor: 28.547

Review 4.  Horizontal gene transfer and the genomics of enterococcal antibiotic resistance.

Authors:  Kelli L Palmer; Veronica N Kos; Michael S Gilmore
Journal:  Curr Opin Microbiol       Date:  2010-09-15       Impact factor: 7.934

5.  BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.

Authors:  Eleni D Lagadinou; Alexander Sach; Kevin Callahan; Randall M Rossi; Sarah J Neering; Mohammad Minhajuddin; John M Ashton; Shanshan Pei; Valerie Grose; Kristen M O'Dwyer; Jane L Liesveld; Paul S Brookes; Michael W Becker; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2013-01-17       Impact factor: 24.633

6.  Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.

Authors:  Byoung-San Moon; Woo-Jeong Jeong; Jieun Park; Tae Il Kim; Do Sik Min; Kang-Yell Choi
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 13.506

7.  Developmental signaling pathways in cancer stem cells of solid tumors.

Authors:  Christina Karamboulas; Laurie Ailles
Journal:  Biochim Biophys Acta       Date:  2012-11-27

8.  Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.

Authors:  Luke Piggott; Nader Omidvar; Salvador Martí Pérez; Rhiannon French; Matthias Eberl; Richard W E Clarkson
Journal:  Breast Cancer Res       Date:  2011-09-14       Impact factor: 6.466

9.  LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.

Authors:  Bei Wang; Queting Chen; Yang Cao; Xia Ma; Chenxing Yin; Youchao Jia; Aimin Zang; Wufang Fan
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

Review 10.  Mammary Development and Breast Cancer: A Wnt Perspective.

Authors:  Qing Cissy Yu; Esther M Verheyen; Yi Arial Zeng
Journal:  Cancers (Basel)       Date:  2016-07-13       Impact factor: 6.639

View more
  27 in total

Review 1.  Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer.

Authors:  Fan Lei; Xinyuan Xi; Surinder K Batra; Tatiana K Bronich
Journal:  J Pharmacol Exp Ther       Date:  2019-02-22       Impact factor: 4.030

Review 2.  Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.

Authors:  Anoop K Yadav; Neetin S Desai
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

Review 3.  Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells.

Authors:  Susmita Barman; Iram Fatima; Amar B Singh; Punita Dhawan
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 4.  MicroRNAs, Hypoxia and the Stem-Like State as Contributors to Cancer Aggressiveness.

Authors:  Lucy Wanjiku Macharia; Caroline Muriithi Wanjiru; Marianne Wanjiru Mureithi; Claudia Maria Pereira; Valéria Pereira Ferrer; Vivaldo Moura-Neto
Journal:  Front Genet       Date:  2019-02-20       Impact factor: 4.599

5.  Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM.

Authors:  Yu-Shui Ma; Zhi-Jun Wu; Hong-Wei Zhang; Bo Cai; Tao Huang; Hui-Deng Long; Hong Xu; Yong-Zhong Zhao; Yu-Zhen Yin; Shao-Bo Xue; Liu Li; Cheng-Lin Liu; Ru-Ting Xie; Lin-Lin Tian; Ji-Bin Liu; Xu-Ming Wu; Da Fu
Journal:  Mol Ther Oncolytics       Date:  2019-05-22       Impact factor: 7.200

Review 6.  Different Shades of L1CAM in the Pathophysiology of Cancer Stem Cells.

Authors:  Marco Giordano; Ugo Cavallaro
Journal:  J Clin Med       Date:  2020-05-16       Impact factor: 4.241

7.  Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.

Authors:  Rama Krishna Nimmakayala; Frank Leon; Satyanarayana Rachagani; Sanchita Rauth; Palanisamy Nallasamy; Saravanakumar Marimuthu; Gautam K Shailendra; Yashpal S Chhonker; Seema Chugh; Ramakanth Chirravuri; Rohitesh Gupta; Kavita Mallya; Dipakkumar R Prajapati; Subodh M Lele; Thomas C Caffrey; Jean L Grem; Paul M Grandgenett; Michael A Hollingsworth; Daryl J Murry; Surinder K Batra; Moorthy P Ponnusamy
Journal:  Oncogene       Date:  2020-10-27       Impact factor: 8.756

8.  Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis.

Authors:  Rohitesh Gupta; Frank Leon; Christopher M Thompson; Ramakrishna Nimmakayala; Saswati Karmakar; Palanisamy Nallasamy; Seema Chugh; Dipakkumar R Prajapati; Satyanarayana Rachagani; Sushil Kumar; Moorthy P Ponnusamy
Journal:  Br J Cancer       Date:  2020-03-19       Impact factor: 7.640

Review 9.  Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion.

Authors:  Peter Kreuzaler; Yulia Panina; Joanna Segal; Mariia Yuneva
Journal:  Mol Metab       Date:  2019-10-10       Impact factor: 7.422

Review 10.  A Shifty Target: Tumor-Initiating Cells and Their Metabolism.

Authors:  Nicole Bezuidenhout; Maria Shoshan
Journal:  Int J Mol Sci       Date:  2019-10-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.